Streamlining Clinical Trial Start-up for Drug Development

This case study details the implementation of strategies and collaborative efforts in a Phase I clinical trial aimed at expediting the start-up process for drug development. It focuses on the partnership between the study team and the sponsor, highlighting the importance of effective communication, strategic planning, and delegation of responsibilities. The study outlines the necessity for Altasciences to reduce the standard start-up time from 12 weeks to less than four weeks, detailing the tasks required within this compressed timeline, such as contract execution, regulatory document preparation, and IRB approval. The case study presents a dual project management structure that facilitated continuous support and direct communication between team leads and the sponsor, which expedited decision-making and issue resolution. Ultimately, the strategies implemented led to a successful start-up timeframe of 3.5 weeks, demonstrating significant reductions in industry-standard timelines and serving as a reference for organizations aiming to enhance their clinical trial operations.